SpyGlass Pharma has randomized the first patients in its 2 registrational phase 3 clinical trials of the Bimatoprost Drug Pad-IOL System (BIM-IOL System) for the lowering of intraocular pressure (IOP) ...
Join the ATN Summit 2026 in London: architects and innovators explore emerging technologies, BIM, AI, and the future of architectural practice.
Every game is the result of thousands of choices. Some of these choices are creative, some technical, and some concern the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results